Skip to main content

Shree Ganesh Remedies Share Price

₹ 616.05

-4.30(0.69%)
Price as of 19 Nov 2026 15:31. Log in to view Live prices

Shree Ganesh Remedies Share Price Chart

Shree Ganesh Remedies Performance

Days Range

Low: ₹612.45

High: ₹620.60

Previous Close₹620.35
Open₹620.60
Volume2,745
Day's Range₹612.45 - ₹620.60
52W Range₹477.05 - ₹749.85
Market Cap₹793.24 Cr

Shree Ganesh Remedies Fundamentals

ROCE(TTM)9.91
P/E Ratio (TTM)65.52
P/B Ratio4.79
Industry P/E40.13
Debt to Equity0.16
ROE7.31
EPS (TTM)9.43
Dividend YieldN/A
Book Value129.11
Face Value10
ROCE(TTM)9.91
P/E Ratio (TTM)65.52
P/B Ratio4.79
Industry P/E40.13
Debt to Equity0.16
ROE7.31
EPS (TTM)9.43
Dividend YieldN/A
Book Value129.11
Face Value10

Shree Ganesh Remedies Financials

Dec 2025Mar 2026Jun 2026Sep 2026
Net Sales21.1133.2014.3623.29
Expenses17.0424.6213.4521.86
Profit before tax3.988.721.532.26
Operating Profit3.096.271.121.63
Net Profit3.096.271.121.63
EPS in Rs2.414.880.871.27

Shree Ganesh Remedies Shareholding Pattern

Promoters
72.84%
Retail And Others
26.17%
Foreign Institutional Investors
0.00%
Domestic Institutional Investors
0.99%

About Shree Ganesh Remedies

Shree Ganesh Remedies Limited was originally incorporated as a private company as 'Shree Ganesh Remedies Private Limited' at Ahmedabad on April 27, 1995. Subsequently the Company was converted into a Public Limited named 'Shree Ganesh Remedies Limited' on July 28, 2017. The Company has carved a niche in the industry of manufacturing pharmaceutical intermediates and fine chemicals. Shree Ganesh Remedies is a ISO 9001:2015, ISO 14001:2015 BS and OHSAS 18001:2007 certified Company and is engaged in manufacturing and dispatch of drug intermediates and chemicals like amine hydrochloride and specialty fine chemicals for pharmaceutical industry. The Company manufactures products relating to antipsychotic, antiseptic, deprotonation reactions, hyperlipidemia, alzheimers and anti-viral. The Products are manufactured for export market and also for domestic and foreign markets. The Company entered the International market in 2006 and are on regular basis exporting its products to various countries. The manufacturing facility is divided into three manufacturing plants namely Plant I, II and III spread across 9715 square meters having different product manufacturing capabilities and process. The manufacturing process is supported by Total Quality Management techniques and is supervised through various quality control equipment's and qualified personnel. The Products are manufactured for export market and also for domestic and foreign markets. In October 2017, the Company came up with a Public Issue of 23,76,000 Fresh Equity Shares by raising equity funds aggregating to Rs 8.56 Crores. In Unit I, Plant 5 was commissioned and made operational in 2018. In 2019, the Company started commercial production at the new production plant at GIDC, Ankleshwar. It acquired Ashok Pharma Chem (Partnership Firm) on December 24, 2019. In 2020, it launched New Advance Pharmaceutical Intermediates substituting the import intermediates. High Pressure Reaction Block was commissioned in 2023. The Company commissioned Block 8 in 2025. In FY 2026, it completed the pilot trials for CRAMS projects, commissioned a new pilot facility and advanced Block 7 towards commissioning.

Parent Organisation
Indian Private
Managing Director
Chandubhai Kothia
Founded
1995
NSE Symbol
SGRL

Shree Ganesh Remedies Share Price History

Data is not available currently. Please check back later.

Top Mutual Funds Invested in Shree Ganesh Remedies Share

Data is not available currently. Please check back later.

Peer Comparison

StocksLTP (₹)Market Cap (cr)52 Week Low-High (₹)
Sun Pharmaceutical Industries Ltd1,910.0Price increase
38.50 (2.06%)
₹4,49,227.491,583.7 - 2,046.9
Divis Laboratories Ltd11,135.5Price increase
86.50 (0.78%)
₹2,93,873.725,647.5 - 11,824.0
Torrent Pharmaceuticals Ltd4,628.0Price increase
17.30 (0.38%)
₹1,76,412.713,672.3 - 5,250.0
Laurus Labs Ltd2,298.2Price decrease
-24.30 (-1.05%)
₹1,25,460.50917.95 - 2,488.0
Zydus Lifesciences Ltd1,199.2Price decrease
-2.80 (-0.23%)
₹1,19,201.71835.5 - 1,266.6
Dr Reddys Laboratories Ltd1,397.7Price decrease
-0.50 (-0.04%)
₹1,16,603.911,101.0 - 1,414.9

Shree Ganesh Remedies Ltd FAQs

Yes, You can buy Shree Ganesh Remedies Ltd (SGRL) shares by opening a Demat account with Angel One.
Shree Ganesh Remedies Ltd (SGRL) share can be bought through the following modes:
1. Direct investment: You can buy Shree Ganesh Remedies Ltd (SGRL) shares by opening a Demat account with Angel One.
2. Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Shree Ganesh Remedies Ltd (SGRL) shares.